Dr. Wargin has over 30 years of experience working in clinical pharmacology, pharmacokinetics, biopharmaceutics, and scientific writing. Dr. Wargin provides expertise in all aspects of pre-clinical and clinical pharmacokinetics including study design, clinical and toxicokinetic data analysis, report writing, IND and NDA PK section authorship.
Dr. Wargin’s therapeutic area experience includes oncology, CNS, cardiovascular disease, and critical care relative to Phase 1 studies. Dr. Wargin has worked on over 20 approved drugs, 20 NDAs, 2 BLAs, 5 ANDAs, ~50 INDs, and over 100 PK Analyses. He has authored or co-authored of over 30 journal articles in pharmacokinetics/biopharmaceutics.